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Abstract Achieving confidence in the causality of a disease locus is a complex task that often
requires supporting data from both statistical genetics and clinical genomics. Here we describe a
combined approach to identify and characterize a genetic disorder that leverages distantly related
patients in a health system and population-scale mapping. We utilize genomic data to uncover
components of distant pedigrees, in the absence of recorded pedigree information, in the multi-
ethnic BioMe biobank in New York City. By linking to medical records, we discover a locus
associated with both elevated genetic relatedness and extreme short stature. We link the gene,
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COL27A1, with a little-known genetic disease, previously thought to be rare and recessive. We
demonstrate that disease manifests in both heterozygotes and homozygotes, indicating a common
collagen disorder impacting up to 2% of individuals of Puerto Rican ancestry, leading to a better
understanding of the continuum of complex and Mendelian disease.
DOI: https://doi.org/10.7554/eLife.25060.001
Introduction
During the past two decades major advances in deciphering the genetic basis of human disease
have resulted in thousands of disorders that are now understood at a genetic level (Hamosh et al.,
2000; McCarthy et al., 2013). This progress has led to the integration of genomic sequencing in
clinical care, especially for the diagnosis of rare genetic disease (Bamshad et al., 2011;
Manolio et al., 2013), and clinical sequencing is increasingly offered to patients with known or sus-
pected genetic disorders. In the past few years, large national and international efforts
(Manolio et al., 2015; Philippakis et al., 2015; Chong et al., 2015a) have emerged to enable
patients and health systems to share knowledge of rare genetic disorders and improve genetic test-
ing, resulting in improved healthcare management and outcomes for patients. In parallel, many large
regional and national biobank efforts (Collins and Varmus, 2015; Ashley, 2015; Collins, 2012) are
underway to enable the broad integration of genomics in health systems for genetic identification of
disease (Dewey et al., 2016). Such efforts have recently revealed clinically actionable variants
(Dewey et al., 2016; Feldman, 2016) and genetic disorders segregating at higher frequencies in
general patient populations than previously suspected. The increased promulgation of genomics in
health systems represents an opportunity to improve diagnostic sensitivity for more precise thera-
peutic intervention and better health outcomes (Ashley, 2016).
Despite this progress, most genetic diseases are still under-diagnosed (Abul-Husn et al., 2016)
or misdiagnosed (Yang et al., 2014; Taylor et al., 2015; Centers for Mendelian Genomics et al.,
2015b). A number of barriers exist for wholesale genetic testing and diagnoses, including incom-
plete standardized guidelines for interpreting genetic evidence of disease (Amendola et al., 2016),
variable penetrance or expressivity of phenotype (Katsanis, 2016), and that the causal variant may
be missed or mis-assigned during testing (Manrai et al., 2016). The latter is a particularly pernicious
problem in non-European populations due to systematic biases in large genomic and clinical data-
bases (Popejoy and Fullerton, 2016; Petrovski and Goldstein, 2016). These challenges have led
several research groups to attempt to genetically identify disease by examining patient health pat-
terns using data from the Electronic Health Record (EHR) (Gottesman et al., 2013; Green et al.,
2016). EHRs contain comprehensive information on medical care throughout a patient’s life, includ-
ing medications, medical billing codes, physician notes and generated reports (i.e. pathologic,
genetic and radiologic reports). EHRs have been used to clinically characterize well-known genetic
disorders, but have been of limited success for the vast cadre of less-characterized or unknown dis-
orders (Blair et al., 2013).
The gold standard of genetic disorder diagnosis involves testing both patient and family mem-
bers to confirm Mendelian segregation of the suspected underlying pathogenic variant
(ClinGen et al., 2015; ClinGen Resource et al., 2015; Gahl et al., 2016). However, as genomic data
becomes more ubiquitous in health systems, it can be used to detect genetic relationships in the
absence of known family and pedigree information. Specifically, components of pedigrees can be
uncovered within the general population; particularly those that have experienced recent founder
effects. Pairs of individuals who are related share genetic homology in the form of long genomic
haplotypes. These haplotypes are considered to be identical-by-descent (IBD) if they are inherited
from a common ancestor without any intervening recombination. The chance of any two people
sharing a tract of their genome IBD decays exponentially, with a ~50% reduction in the chance of
sharing per generation. However, when IBD sharing does occur, the length of an IBD segment can
remain long even between distantly related individuals. In practice, long tracts of IBD (>3 cM) can be
accurately detected using genetic data between individuals with a common ancestor from the past
4–50 generations (Browning and Browning, 2012). Detection of IBD haplotypes can allow for the
identification of distantly related patients with a genetic disorder driven by a locus inherited from a
founding ancestor who brought the disease mutation into a population (Houwen et al., 1994;
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Kenny et al., 2009; Henden et al., 2016; Meta-Analysis of Glucose and Insulin-related traits Con-
sortium (MAGIC) et al., 2010; Traherne et al., 2016; Shaw et al., 2015; Ko et al., 2014;
Lalli et al., 2014). This is the principle underlying population-scale disease mapping approaches that
combine IBD sharing and statistical association to discover novel disease loci, so called IBD-
mapping.
By detecting genetic relatedness, as inferred by IBD sharing, we hypothesized that we may be
able to detect hereditary forms of disease in an EHR-linked biobank. With over 38000 participants,
the BioMe biobank, at the Icahn School of Medicine at Mount Sinai, New York City (NYC), is one of
the most diverse cohorts ascertained at a single urban medical center under a uniform study proto-
col. Participants are largely from the local Upper East Side, Harlem and Bronx communities, and rep-
resent broad ancestral, ethnic, cultural, and socioeconomic diversity. We initially focused on adult
height, which is easily measurable, stable over the adult life course, and one of the most abundantly
recorded clinical parameters in EHRs. Height is known to be highly heritable and polygenic
(Visscher et al., 2010; Lango Allen et al., 2010), however, extremes of short stature can be caused
by rare variants in single genes with large effect sizes (Durand and Rappold, 2013a). Although,
many genetic syndromes are known to cause short stature, most of the time no definitive etiology
underlying short stature is found in patients. Here we used loci associated with elevated genetic
relatedness as measured by IBD to map a locus underlying extreme short stature in the BioMe bio-
bank, and linked it to a known, but little characterized, collagen disorder previously thought to be
rare. By interrogating a large global diversity panel, we demonstrated that this variant is actually
common in Puerto Rican populations. Furthermore, we leveraged the EHR to show significant mus-
culoskeletal disease in both heterozygous and homozygous patients, indicating the disease is not
simply a recessive disorder as had previously been thought. Finally, we showed how this work can
generate broad insights for sustainable adoption and large-scale dissemination of genomic
medicine.
eLife digest Diseases often run in families. These disease are frequently linked to changes in
DNA that are passed down through generations. Close family members may share these disease-
causing mutations; so may distant relatives who inherited the same mutation from a common
ancestor long ago. Geneticists use a method called linkage mapping to trace a disease found in
multiple members of a family over generations to genetic changes in a shared ancestor. This allows
scientists to pinpoint the exact place in the genome the disease-causing mutation occurred. Using
computer algorithms, scientists can apply the same technique to identify mutations that distant
relatives inherited from a common ancestor.
Belbin et al. used this computational technique to identify a mutation that may cause unusually
short stature or bone and joint problems in up to 2% of people of Puerto Rican descent. In the
experiments, the genomes of about 32,000 New Yorkers who have volunteered to participate in the
BioMe Biobank and their health records were used to search for genetic changes linked to
extremely short stature. The search revealed that people who inherited two copies of this mutation
from their parents were likely to be extremely short or to have bone and joint problems. People who
inherited one copy had an increased likelihood of joint or bone problems.
This mutation affects a gene responsible for making a form of protein called collagen that is
important for bone growth. The analysis suggests the mutation first arose in a Native American
ancestor living in Puerto Rico around the time that European colonization began. The mutation had
previously been linked to a disorder called Steel syndrome that was thought to be rare. Belbin et al.
showed this condition is actually fairly common in people whose ancestors recently came from
Puerto Rico, but may often go undiagnosed by their physicians. The experiments emphasize the
importance of including diverse populations in genetic studies, as studies of people of
predominantly European descent would likely have missed the link between this disease and
mutation.
DOI: https://doi.org/10.7554/eLife.25060.002
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Results
Detecting patterns of diversity, founder effects and relatedness in the
BioMe biobank from New York City
The BioMe biobank comprises a highly diverse cohort, with over 65% of participants self-reporting
as Black/African-American or Hispanic/Latino/a, and over 35% born outside mainland US, represent-
ing more than 110 countries of origin. First we estimated patterns of direct relatedness in a subset
of BioMe participants genotyped on the Illumina OmniExpress array (N = 11212) by detecting pair-
wise identity-by-state using RELATEAdmix (Moltke and Albrechtsen, 2014), a method that
accounts for admixture in populations (Figure 1—figure supplement 1). We observed that 701 indi-
viduals had primary (parent-child, sibling) or secondary (avuncular, grandparental) relationship with
another participant in BioMe, and we removed these individuals from all downstream analysis. Next
we devised a strategy to divide the diverse BioMe biobank into population groups for downstream
analysis. We combined genotype data for BioMe participants (N = 10511) with 26 global populations
from the 1000 Genomes Project (1KGP; N = 2504) (The 1000 Genomes Project Consortium, 2015)
and two additional panels of Native American (N = 43) (Mao et al., 2007) and Ashkenazi Jewish
populations (N = 100) (see Methods). Using a common set of 174468 SNPS we performed principal
component analysis (Price et al., 2006) (PCA; Figure 1—figure supplement 2). Based on both self-
reporting and patterns of genetic diversity observed in BioMe participants, we stratified individuals
into four broad population groups. The first group self-reported as European American, but were
also genetically identified as Ashkenazi Jewish (AJ; N = 808) as they clustered distinctly with an AJ
reference panel and separately from other European ancestry groups in PCA space (Figure 1—fig-
ure supplement 3). The other three groups we defined using self-reported race/ethnicity categories,
African-American (AA; N = 3080), Hispanic/Latino/a (H/L; N = 5102) and European-Americans with
no AJ genetic ancestry (Non-AJ EA; N = 1270) (Figure 1—figure supplement 3). An additional 251
individuals who reported ‘Mixed’ (N = 89) or ‘Other’ (N = 162) ethnicity were excluded from further
analysis.
To evaluate signatures of distant relatedness BioMe biobank participants, we estimated sharing
of genomic tracts IBD >3 cM between every pair of individuals using the GERMLINE software
(Gusev et al., 2009). The minimum length of 3 cM was chosen based on reports of elevated type I
error in call rates of smaller lengths (Gusev et al., 2012; Chiang et al., 2016). It is known that popu-
lation-level rates of distant relatedness are observed to be particularly elevated after population bot-
tlenecks (i.e. in founder populations) (Browning and Thompson, 2012). We summed the length of
all IBD-tracts shared between a given pair of individuals if they shared more than one tract and
examined the distribution of pairwise sharing at a population level. We observed elevated levels of
distant relatedness in both the AJ (median summed length of IBD sharing within population = 44.7
cM; 95% C.I. = 44.66–44.82 cM) and HL (16.2 cM; 16.18–16.22 cM) populations, compared to AA
(3.77 cM; 3.76–3.77 cM) or non-AJ EA (4.5 cM; 4.45–4.55 cM) populations (Figure 1A). This is con-
gruent with previous reports of founder effects in both AJ populations (Need et al., 2009) and in
some H/L populations (Moreno-Estrada et al., 2013).
Hispanic or Latino/a is a broad ethnic label encompassing myriad populations with origins in
Northern, Southern or Central America, century-long roots in New York City, and genetic ancestry
from Africa, Europe and the Americas. To explore the signature of a founder effect in the BioMe H/L
population, we leveraged self-reported and genetic information about sub-continental ancestry. By
self-reporting, the H/L participants in BioMe were born in New York City (NYC) (40%), Puerto Rico
(24%), Dominican Republic (19%), Central/South America (12%), Mexico (2%) or other Caribbean
Island (2%) (Figure 1B). We examined IBD tract length distributions within H/L sub-continental popu-
lations and observed that the founder effect was predominantly driven in the Puerto Rican-born
group (Figure 1C). We assembled a cohort of Puerto Ricans including BioMe participants who were
either born in Puerto Rico or, were born in NYC and had 2 parents or 3–4 grand parents who were
born in Puerto Rico (N = 1245). Approximately 5086 NYC-born H/L individuals did not have
recorded parental or grandparental country-of-origin, therefore we also devised a selection strategy
using PCA analysis. We identified BioMe H/L participants on the cline between the African and Euro-
pean reference panels in PCA space coincident with Puerto Rican-born individuals. We excluded
those on the same cline with ancestry from the Dominican Republic or another Caribbean Island (Fig-
ure 1—figure supplement 4), and counted the remainder (N = 1571) in the Puerto Rican group. In
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Figure 1. Distribution of Identity-by-Descent sharing among BioMe populations. (A) Distribution of the pairwise sum of Identity-by-Descent (IBD)
sharing (cM) between four broadly defined BioMe populations, namely; African American (AA), Ashkenazi Jewish (AJ), Hispanic/Latino/a (H/L) and Non-
Jewish European American (Non-AJ EA). (B) Sub-continental diversity in self-reported H/L participants in BioMe. Afro-Caribbean participants fall
between European (red) and African (blue) continental reference panels, Mexican and Central/South American H/L participants fall between European
and Native American (green) reference panels, mainland US-born participants reside on either cline. (C) The tract length distribution of IBD sharing
among BioMe populations, normalized by population size. The y-axis represents the proportion population-level sharing (x / (N*(N-1)/2)), where x is the
sum of the number of pairwise shared IBD tracts and N is the number of individuals per population. The AJ population exhibits the highest level of
population level sharing, followed by Puerto Rican born H/L.
DOI: https://doi.org/10.7554/eLife.25060.003
The following figure supplements are available for figure 1:
Figure supplement 1. Identity-by-State analysis to test for presence of relatedness in four BioMe populations.
DOI: https://doi.org/10.7554/eLife.25060.004
Figure supplement 2. Principal Component Analysis of all BioMe participants show extensive global genetic diversity.
DOI: https://doi.org/10.7554/eLife.25060.005
Figure supplement 3. Principal Component Analysis in BioMe AA and EA reveals sub-continental structure.
DOI: https://doi.org/10.7554/eLife.25060.006
Figure supplement 4. Inference of suspected Puerto Rican ancestry individuals via principal component analysis.
DOI: https://doi.org/10.7554/eLife.25060.007
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total, we estimated 2816 H/L in the BioMe discovery cohort were of Puerto Rican ancestry, and
focused the downstream analysis on this group as the largest founder population in BioMe.
Detecting a locus shared identical-by-descent underlying extreme short
stature in Puerto Ricans
Next we tested the hypothesis that rare, recessive disease variants may have arisen to appreciable
frequency in the Puerto Rican founder population. We linked genomic data to clinical data in the
Electronic Health Record (EHR) of the Mount Sinai Health System. We focused on height, a stable
and ubiquitous health measure. Clinically, rare instances of growth failure or ‘short stature’ may be
caused by a large heterogeneous group of genetic disorders (i.e. skeletal dysplasias) (Durand and
Rappold, 2013b). We first extracted measures of height for the Puerto Rican adult population of
BioMe (mean age = 55.3, standard deviation (s.d.)=16.1). After making exclusions based on age
(>=18 years old for women, >=22 years old for men, and <80 years old in both sexes, 194 individu-
als in total), mean height measurements (mean height = 5’ 8.2’, s.d. = 3.2’ for men; mean height =
5’ 2.8’ s.d. = 2.8’ for women) were consistent with those reported for Puerto Rican populations in a
recent global study on height (NCD Risk Factor Collaboration (NCD-RisC), 2016). We noted that
56 Puerto Ricans met the clinical definition of short stature (Cohen et al., 2008) (range of short stat-
ure 5’1’ 4’0’ in men, and 4’8’ 3’8’ in women) defined as 2 standard deviations below the popula-
tion-specific mean for men and women separately (Figure 2—figure supplement 1).
To test for recently arisen, recessive variants underlying clinical short stature in Puerto Ricans, we
implemented a previously published pipeline for ‘IBD mapping’ (Kenny et al., 2009; Vacic et al.,
2014) (Figure 2—figure supplement 2). We first clustered participants into ‘cliques’ of 3 or more
individuals whom, at a given genomic region, shared overlapping homologous IBD tracts of at least
0.5 cM in length in either a heterozygous or homozygous state. Membership in a clique indicates the
sharing of a recent common ancestor at that locus, from which the homologous IBD tract was jointly
inherited. Clustering of IBD into cliques in the Puerto Rican population (N = 2816) yielded 1434421
IBD-cliques after quality control filters (see Methods). The site frequency spectrum of IBD-cliques
(Figure 2—figure supplement 3) demonstrates an expected exponential distribution of clique sizes
(of 3–77 haplotypes), representing a class of rare IBD haplotypic alleles (allelic frequency 0.0005–
0.0137). To test whether any cliques of IBD haplotypes were significantly associated with height we
performed genome-wide association of height as a continuous trait under a recessive model using
PLINKv1.9 (Purcell et al., 2007; Chang et al., 2015), including the first five PCA eigenvectors as
covariates (see Materials and methods). We restricted analysis to 480 out of 1434421 cliques that
contained at least 3 individuals who were homozygous for the shared haplotype. Adjusting for 480
tests (Bonferroni adjusted threshold p<110 4) one IBD-clique achieved a genome-wide significant
signal at the locus 9q32 (IBD-clique frequency = 0.012; b =  3.78; p<2.5710 11) (Figure 2A), span-
ning a large mapping interval chr9:112 MB-120MB. The clique contains 59 individuals, 56 of whom
are heterozygous and 3 are homozygous for the associated IBD haplotype.
Fine-mapping short stature locus reveals putative link to mendelian
syndrome
The three individuals driving the recessive signal, two women and one man, were less than 2.5 s.d.
shorter (height reduction range 6’ 10’) than the population mean for height in the Puerto Rican
cohort (Figure 2B). The IBD-haplotypes driving the signal spanned a genic region with several candi-
date loci, and the minimum shared boundary overlapped a single gene, COL27A1, which encodes
for Collagen Type XXVII, Alpha 1 (Figure 2C). We performed whole genome sequencing (WGS) of
the three homozygous individuals, and an additional short-statured individual that we observed to
possess a homozygous IBD haplotype that was both directly upstream of and highly correlated with
the top IBD-clique. Individuals were sequenced to a depth of 4-18X coverage (Supplementary file
1). Examination of variants that were observed in at least 6 copies between the four individuals (to
account for sequencing error or missing calls) revealed a single candidate coding allele, a missense
mutation in Collagen Type XXVII, Alpha 1 (COL27A1, g.9:116958257.C>G, NM_032888.1, p.G697R,
rs140950220) (Supplemental file 2). In silico analysis suggest that this glycine residue is highly con-
served, and that a molecular alteration to arginine at this position is predicted to be damaging (SIFT
score = 0.0; PhyloP score = 2.673; GERP NR score = 5.67). These findings are consistent with a
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Figure 2. Identity-by-Descent mapping reveals locus associated with short stature. (A) Identity-By-Descent (IBD) mapping for height in BioMe Puerto
Ricans using a recessive model. Analysis was restricted to IBD-cliques where at least three individuals were homozygous. Only one IBD-clique achieved
Bonferroni significance (at 9q32). (B) Distribution of height among Puerto Rican individuals who carry either 0,1 or 2 copies of the IBD-haplotype reveals
a large recessive effect. Homozygous individuals (those carrying 2 copies of the IBD-haplotype) are on average 6–10’ shorter than the population mean
for Puerto Rican ancestry individuals. (C) The minimum shared boundary of the significant IBD-haplotype between the three homozygous individuals
(represented by the dashed blue line). The top panel depicts known genes at the 9q32 locus. The minimum shared boundary of the IBD overlaps the
gene COL27A1..
DOI: https://doi.org/10.7554/eLife.25060.008
The following figure supplements are available for figure 2:
Figure supplement 1. Distribution of height in the BioMe Puerto Ricans stratified by sex.
Figure 2 continued on next page
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recent report implicating the same COL27A1 variant as causal for the rare orthopedic condition
Steel syndrome in a Puerto Rican family (Gonzaga-Jauregui et al., 2015). First described in 1993,
the main clinical features of Steel syndrome include short stature, bilateral hip and radial head dislo-
cations, carpal coalition (fusion of the carpal bones), scoliosis, pes cavus (high arches), and dysmor-
phic features (Steel et al., 1993).
To confirm the link between the IBD haplotype and the putative causal variant, we calculated the
concordance between the IBD haplotype and carrier status of the COL27A1.pG697R variant by gen-
otyping all of the homozygotes and carriers of the top IBD-clique in the recessive model (N = 59),
along with a panel of age- and sex-matched controls (N = 59). This demonstrated 100% concor-
dance between the COL27A1.pG697R variant and the significant IBD-haplotype in homozygotes
(Supplementary file 3). We note that two Puerto Rican participants in the phase 3 1KGP reference
panel were carriers of the COL27A1.pG697R variant, raising the possibility that we may have been
able to detect this association using more a traditional SNP association approach. Therefore, we per-
formed genome-wide association in the same Puerto Rican cohort (N = 2622) by first imputing the
1KGP panel and re-running the recessive test as described above (n = 10007795 imputed and geno-
typed SNPs with an INFO score of >0.3 and at least two observations of homozygotes). The reces-
sive model appeared to be well calibrated (l = 1.02), however, we observed no genome-wide
significant signal (Figure 2—figure supplement 4). Association with the COL27A1.pG697R variant
was the 11775th most significant association (MAF = 0.014: b =  3.0; p<0.001). Upon examination
of the correlation between the imputed COL27A1.pG697R and the true carrier status of homozy-
gotes, we noted a concordance of only 66.67%, indicating that the IBD haplotype was a better tag
of the true COL27A1.pG697R homozygous state compared to 1KGP imputation in the Puerto Rican
cohort (Supplemental file 3).
The association between COL27A1.pG697R and clinical short stature was replicated using a
cohort of 1775 individuals of self-reported Puerto Rican ancestry from BioMe that were not included
in the discovery analysis, that were genotyped on the Illumina Infinium Multi-Ethnic Genotype Array
(MEGA) as part of the Polygeneic Architecture using Genomics and Epidemiology (PAGE) Study.
The COL27A1.pG697R (rs140950220) variant was directly genotyped on MEGA, and an association
of the variant under a recessive model resulted in a strong signal of association (allele fre-
quency = 0.017; b =  3.5; s.e. = 0.70; p<4.8710 07). The replication analysis revealed 51 additional
BioMe carriers and two individuals that were homozygous for the variant. Both carrier and affected
status was confirmed via independent genotyping and Sanger sequencing (see
Materials and methods). The two homozygous participants were both short statured (2.4 and 3.6 s.d
from the sex specific population mean).
Evidence from electronic health records supports suspected cases of
steel syndrome
To determine whether there was any clinical evidence to validate the link between the COL27A1.
pG697R variant and Steel syndrome, a clinical expert manually reviewed the electronic health
Figure 2 continued
DOI: https://doi.org/10.7554/eLife.25060.009
Figure supplement 2. A framework for biomedical discovery via Identity-by-Descent (IBD) mapping.
DOI: https://doi.org/10.7554/eLife.25060.010
Figure supplement 3. Site Frequency Spectrum of IBD-cliques in BioMe Puerto Ricans follows an exponential distribution.
DOI: https://doi.org/10.7554/eLife.25060.011
Figure supplement 4. Genome Wide Association of Height in N = 2622 Puerto Ricans under a recessive model appears to be well-calibrated but
reveals no genome-wide significant signal.
DOI: https://doi.org/10.7554/eLife.25060.012
Figure supplement 5. A structural model of glycine-to-arginine substitution within a collagen triple helix.
DOI: https://doi.org/10.7554/eLife.25060.013
Figure supplement 6. Depth of IBD-sharing across the genome in BioMe.
DOI: https://doi.org/10.7554/eLife.25060.014
Figure supplement 7. Size of Homologous IBD-Clique Membership Across the Genome in BioMe.
DOI: https://doi.org/10.7554/eLife.25060.015
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records (EHR), including clinical diagnoses, surgical procedures, and radiology reports of the five
participants (3 women, 2 men, age range 34–74 years) homozygous for the COL27A1.pG697R vari-
ant that we had identified through the discovery and replication efforts. Of note, there was no evi-
dence that any of the five patients had a clinical diagnosis of Steel syndrome. In all five individuals,
however, we found EHR-documented evidence of several previously described Steel syndrome char-
acteristics, including developmental dysplasia of the hip (or congenital hip dysplasia), carpal coali-
tion, scoliosis, and cervical spine anomalies (Table 1) (Steel et al., 1993; Flynn et al., 2010). The
incidence of cervical spine anomalies, including cord compression and spine surgeries, was higher
Table 1. Clinical characteristics of five BioMe participants homozygote, thirty-four carriers and thirty-one non-carriers of the
COL27A1.pG697R variant using evidence documented in Electronic Health Records (including billing and procedural codes,
laboratory, radiologic, and progress notes) compared to features previously reported in Flynn et al. (2010), and Steel et al., 1993
for 27 children and 7 adults with Steel syndrome.
Characteristics EHR-Documented evidence
Literature
Homozygous
children
Literature
Homozygous
Adults
BioMe
Homozygous
Adults
BioMe
Heterozygous
Adults
<55yoa
BioMe
Controls
Adults
<55yoa
Sample size (Gender) N (N of females) 27 (9) 7(6) 5 (3) 34(20) 31(23)
Age Mean age (years) 12.8 35.4 51.6 41.8 40.6
Described Characteristics EHR-Documented Medical
History
N(%) N(%) N(%) N(%) N(%)
Short Stature Height >= 2 s.d. from pop mean 27 (100) 7 (100) 5 (100) 0 (0) 0 (0)
Bilateral hip dislocation Congenital hip dislocation 4 0 0
Leg length discrepancy 1 0 0
Total 27(100) 7(100) 5 (100) 0 (0) 0 (0)
Radial head dislocation Elbow contractures 24 (89) 7 (100) 1 (20) 0 (0) 0 (0)
Carpal coalition Wrist deformity 1 2 1
Lunotriquetial fusion 1 0 0
Carpel tunnel 0 3 3
Total 24 (89) 6 (86) 2 (40) 5(15) 4(13)
Scoliosis Scoliosis 12 (44) 6 (86) 2 (40) 8 (24) 4 (13)
Pes cavus Pes cavus 12 (44) 0 (0) 0 (0) 0 (0) 0 (0)
Cervical spine anomalies Cervical stenosis 3 5 0
Cervical discitis 1 0 0
Cervical spondylosis 2 7 3
Cervical cord compression 3 3 1
Total 3 (9) 0 (0) 4 (80) 7 (21) 3 (10)
Other Characteristics EHR-Documented Medical
History
N(%) N(%) N(%)
Other spine anomalies Lumbar spine - - 1 (20) 10 (29) 5 (16)
Thoracic spine - - 1 (20) 5(15) 4(13)
Other skeletal disease Osteoporosis or osteopenia - - 3 (60) 3(9) 1 (3)
Arthritis or degenerative changes - - 3 (60) 13(38) 6 (19)
Relevant surgical
Interventions
Hip replacement - - 3 (60) 0 (0) 0 (0)
Knee replacement - - 2 (40) 0 (0) 0 (0)
Cervical spine - - 3 (60) 2 (6) 1 (3)
Lumbar spine - - 1 (20) 1 (3) 0 (0)
Thoracic spine - - 2 (40) 1 (3) 1 (3)
DOI: https://doi.org/10.7554/eLife.25060.016
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than previously reported (four out of five patients). There was also evidence of other significant mus-
culoskeletal complications, including lumbar and thoracic spine anomalies in three patients, knee
replacements in two patients (both under age 50), and joint degeneration or arthritis in four patients.
Together, these data help further our understanding of Steel syndrome-associated characteristics
and potential complications that can occur later in life.
Functional Investigation of COL27A1.pG697R
To understand the biological mechanism underlying Steel syndrome, we investigated the functional
role of the COL27A1 gene. COL27A1 is a fibrillar collagen, which are a class of collagens that con-
tribute to the structural integrity of the extracellular matrix (Pace et al., 2003). Enrichment of
COL27A1 RNA expression in vertebrae, as well as long bones, eyes, and lungs has previously been
observed in embryonic mice (Pace et al., 2003). A mouse deletion of 87 amino acids of the
COL27A1 homolog exhibited severe chondroplasia consistent with clinical features observed in
homozygotes (Plumb et al., 2011), a similar musculoskeletal phenotype was observed in knockdown
of the col27a1a and col27a1b genes in zebrafish (Christiansen et al., 2009). Type alpha-1 collagen
genes, of which COL27A1 is a member, contain a conserved Gly-Xaa-Yaa repeat in their triple helical
domain (Persikov et al., 2004). Therefore, we hypothesized that the COL27A1.pG697R variant may
similarly disrupt stability of the COL27A1 triple helix.
To test this hypothesis we modeled the effect of a glycine-to-arginine substitution in the structure
of a prototypical collagen peptide (Bella et al., 1994). We observed that the glycine residues occu-
pied the center of the crowded triple helix, and that substitution for a bulkier arginine would likely
destabilize helix formation through steric hindrance (Figure 2—figure supplement 5). These data
provide support for a functional model of the pathogenicity of COL27A1.G697R through destabiliza-
tion of the triple helix, which may occur within developing spinal chords, long bones, and other tis-
sues, resulting in the observed clinical features in homozygotes. We note that many other collagen
disorders, including Ehlers-Danlos syndrome (McGrory et al., 1996; Tromp et al., 1995;
Anderson et al., 1997), Alport syndrome (Knebelmann et al., 1992; Zhou et al., 1992) and Osteo-
genesis Imperfecta (Starman et al., 1989; Shapiro et al., 1992), are driven by molecular alterations
of a glycine in the triple helix of the underlying collagen genes. However, all of these disorders are
inherited under an autosomal dominant mode, in contrast to Steel syndrome, which has only been
reported as a recessive disease. This analysis raises the question of whether some and/or milder clin-
ical features of Steel syndrome may be present in carriers.
Assessing the health records of COL27A1.pG697R carriers reveals
evidence of musculoskeletal disease
To test for clinical features of Steel syndrome in COL27A1.pG697R carriers, we performed two anal-
yses using EHR data. The first was a test for associated medical billing codes (ICD9s) with COL27A1.
pG697R carrier status, or Phenome-Wide Association Study (PheWAS) (Denny et al., 2010;
Denny et al., 2013). PheWAS analysis is often performed using a general linear model (GLM), how-
ever standard implementations often do not account for scenarios where there is a large imbalance
between per-test number of cases and controls, rare variants/ICD9s or the presence of elevated dis-
tant relatedness. Therefore, in addition to the GLM, we also ran three other score based tests; (i)
that use saddlepoint approximation (SPATest) (Dey et al., 2017) to account for case:control imbal-
ance; (ii) a linear mixed model (GCTA) (Yang et al., 2011) to account for distant relatedness; and (iii)
a test that incorporates a bias-reduction for small numbers of observations (Firth test) (Wang, 2014).
Each test was run using ICD9 codes in all individuals of Puerto Rican ancestry (N = 106 COL27A1.
pG697R carriers and N = 4480 non-carriers). The five homozygotes were excluded. The ICD9 code
was set as the outcome variable and COL27A1.pG697R as the primary predictor variable, including
age, sex and the first five PCAs as covariates in all tests. To avoid spurious associations, we restricted
the analysis to diagnosis codes with at least 3 observations (n = 367 ICD9 codes) amongst carriers.
Results of the GLM test are shown in Figure 3 and Table 2. Of the five significantly associated
ICD9 codes (False Discovery Rate (FDR) < 0.05), three involved the musculoskeletal system 730.08
(pGLM < 7.1  10
 6; odds ratio (OR) = 34.5; 95% Confidence Interval (CI) = 7.4–162), 721.0 (pGLM <
6.6  10 5; OR = 5.4; CI = 2.4–12.3), and 716.98 (pGLM < 4.4  10
 4; OR = 5.8; CI = 2.2–15.3). ICD9
730.08 encodes for ‘acute osteomyelitis, other specified sites’. Manual review of chart records for
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these patients revealed that this code referred to vertebral osteomyelitis in the three carriers with
the ICD9 code. ICD9 721.0 encodes for cervical spondylosis without myelopathy. Cervical spondylo-
sis refers to degenerative changes of the cervical spine, which can eventually progress to encroach
on the cervical canal, causing myelopathy (spinal cord injury). A third diagnosis code, 716.98,
Figure 3. Phenome-Wide Association Study (PheWAS) of COL27A1.pG697R carriers vs ICD9 billing codes derived from the Electronic Health Records
(EHR) under a general linear model (GLM). Five billing codes achieve significance (FDR adjusted p<0.05). Three of the five significant ICD9 codes are in
category of musculoskeletal disorders.
DOI: https://doi.org/10.7554/eLife.25060.017
The following figure supplement is available for figure 3:
Figure supplement 1. Phenome Wide Association (PheWAS) under three alternative models.
DOI: https://doi.org/10.7554/eLife.25060.018
Table 2. Top five significantly PheWAS associated ICD9 codes in COL27A1.pG697R carriers (N = 106) compared to non-carriers
(N = 4480).
Disease
category
ICD9
code Short description
Number of diagnoses
among carriers
N (%)
Number of diagnoses
among non-carriers
N (%)
Odds ratio
(5% confidence
intervals)
P-
value
Neoplasms 622.10 Dysplasia of cervix, not otherwise
specified
6 (5.7) 62 (1.4) 5.4 (2.3–12.6) 1.0 
10–4
Musculoskeletal 716.98 Arthropathy unspecified, involving
other unspecified sites
4 (3.8) 48 (1.1) 5.8 (2.2–15.3) 4.4 
10–4
Musculoskeletal 721.00 Cervical spondylosis without
myelopathy
5 (4.5) 74 (1.6) 5.4 (2.4–12.3) 6.6 
10–5
Musculoskeletal 730.08 Acute osteomyelitis involving other
specified sites
3 (2.8) 6 (0.1) 34.5 (7.4–162) 7.1 
10–6
Digestive 789.10 Hepatomegaly 3 (2.8) 17 (0.4) 11.6 (3.2–42.2) 2.1 
10–4
DOI: https://doi.org/10.7554/eLife.25060.019
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encodes for ‘arthropathy, unspecified, or involving other specified sites’. Manual review of chart
records for these patients revealed that this code referred to knee arthropathy in all four patients.
Finally, two other ICD9 codes were significantly associated with the COL27A1.pG697R variant;
622.10 (pGLM < 1  10
 4; OR = 5.4; CI = 2.3–12.6), which encodes for cervical dysplasia, and 789.1
(pGLM < 2.1  10
 4; OR = 11.6; CI = 3.2–42.2), which encodes for hepatomegaly. Presently, it is
unclear whether these two are related to a COL27A1.pG697R carrier phenotype, or are spurious
associations.
We observed over inflation in the distribution of the PheWAS test statistic, measured by lambda
(l), for all four score based models (lGLM=1.59; lSPATest=1.20; lGCTA=1.36; lFirth=2.09), indicating
that no single model fully accounts for the confounding effects of distant relatedness, case:control
imbalance and rare variants/ICD9s (Figure 3—figure supplement 1). The code linked to vertebral
osteomyelitis (730.08) was the top signal in all tests (pSPATest < 1.4  10
 4; pGCTA < 7.9  10
 10;
pFirth < 1.5  10
 9), but only remains significant after genomic control adjustment in one of the tests
(pGCTA_adjusted < 4.6 x 10
 5). Neither codes linked to cervical spondylosis (721.0; pSPATest < 3.0 
10 3 (rank=3rd); pGCTA < 3.3  10
 3 (8th)) or knee arthropathy (716.98; pSPATest < 0.022 (21st); pGCTA
< 3.5  10 3 (9th); pFirth < 0.001 (35th))) were significant after genomic control correction. Therefore,
while PheWAS analysis provided preliminary support of Steel syndrome-associated clinical features
in carriers, best practices for PheWAS models for rare variants/ICD9 codes, and in the presence of
population structure, remains an open problem for the genomics community. It is also possible that
some relevant clinical features of Steel syndrome might be poorly captured by or absent from medi-
cal billing codes.
To evaluate the preliminary evidence from the PheWAS analysis, we performed a second analysis
of EHR data that focused on a comprehensive manual chart review to examine for evidence of Steel
syndrome characteristics in the COL27A1.pG697R carriers in the same manner as performed for
homozygotes. We limited the analysis to carriers below the age of 55 (N = 34; mean age 41.8 years)
to reduce confounding from age-related related symptoms of spine and joint pain. We also selected
31 age and sex matched Puerto Rican non-carriers for comparison (mean age 40.6 years). Utilizing
the same criteria used to characterize Steel syndrome cases, we found no evidence of clinical short
stature or hip dislocation in carriers, but did observe a trend of elevated rates of major joint and
spine degradation (Table 1). In general, 38% (13/34) of carriers showed evidence of spine degenera-
tion varied from severe (multiple level cord compression and neurological symptoms necessitating
corrective surgery) to moderate (lower back pain with no neurological symptoms managed with
physical therapy and/or pain medication) compared to 13% (4/31) of non-carriers (Fishers exact test
p<0.03). Specifically, we found an increased risk of cervical stenosis in 15% (5/34) of carriers com-
pared to 0% (0/31) of controls (p<0.05). Although not reaching statistically significance, we show a
trend of 2-fold higher rates of scoliosis (24%; p<0.35), arthritis (38%; p<0.1), and lumbar spine deg-
radation (29%; p<0.25) in carriers compared to non-carriers and previous published reports in similar
age groups (Kebaish et al., 2011; Reginster, 2002). Together these data suggest an appreciable
burden of joint and spine degradation in COL27A1.pG697R carriers (Table 1).
Worldwide frequency and demographic history of COL27A1.pG69R
Having genetically identified and clinically characterized a previously little-known disease variant, we
next investigated which populations were at risk for harboring the allele. We assessed the carrier fre-
quencies of the COL27A1.pG697R variant in global panel of 51745 individuals from Africa (N = 376),
the Americas (N = 45685), Asia (N = 5311), Europe (N = 209), the Middle East (N = 163) and Oce-
ania (N = 28) genotyped on MEGA in the PAGE Study. This included; 13050 in the Multi-Ethnic
Cohort (MEC) (Kolonel et al., 2000) Study; 12327 in the Hispanic Community Health Study/Study of
Latinos (HCHS/SOL) (Lavange et al., 2010); 12852 in the Women’s Health Initiative (WHI) Study
(The Women’s Health Initiative Study Group, 1998); 13044 additional BioMe biobank participants
(including the 1775 Puerto Ricans on MEGA described above); and a Global Reference Panel from
Stanford University including the Human Genome Diversity Panel (Cann, 2002) (N = 986, see
Materials and methods). Combined, the PAGE and BioMe dataset represented 57316 individuals
from 112 global populations (Supplementary file 4). The COL27A1.pG697R C allele was present in
183 copies (173 heterozygous carriers and 5 homozygous cases). We estimate the carrier rate of
COL27A1.G697R to be 1:51 in Puerto Rican-born individuals (minor allele frequency (MAF) = 1.1%);
1:9 in individuals born on the island of St. Thomas (MAF = 11%); 1:346 in Hispanic/Latino/as in the
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US (MAF = 0.29%) and 1:72 in BioMe Hispanic/Latino/a populations from New York City
(MAF = 0.7%); and 1:746 in individuals born in the Dominican Republic (MAF = 0.067%) (Figure 4A).
We note that only 9 people were assayed from St. Thomas, so the high carrier frequency estimate
could be biased by small sample size. Finally, the variant is present in only 4 copies in the 60,706
exomes in the ExAC database (Exome Aggregation Consortium et al., 2016), likely due to differen-
ces in the populations comprising both datasets.
Figure 4. Allele frequency distribution and demographic history of COL27A1.pG697R. (A) Global carrier frequency of COL27A1.pG697R in a multi-
ethnic database of over 57,000 individuals representing 112 populations. The variant is absent or very rare in most populations (purple), at 1:746 and
1:346 carrier frequency amongst individuals from the Dominican Republic and Hispanic/Latino/as in the United States (green), and at 1:51 and 1:9
carrier frequency amongst individuals from Puerto Rico and St. Thomas (yellow). (B) Joint analysis of identity-by-descent and local ancestry haplotypes
in three individuals homozygous for the COL27A1.pG697R variant. A large 15 cM interval on chromosome 9 is shown with local ancestry inferred as
African (blue), European (red) and Native American (green), with shading to indicating the boundaries of the IBD haplotypes. The location of COL27A1
is indicated by the dashed line (C) Effective population size of the Puerto Rican discovery population (N = 2816) over the past 4–25 generations inferred
from the tract length distribution of IBD haplotypes suggests that the ancestral population underwent a bottleneck approximately 9–14 generations
ago. 95% confidence intervals are represented by blue ribbon.
DOI: https://doi.org/10.7554/eLife.25060.020
The following figure supplements are available for figure 4:
Figure supplement 1. Integrated haplotype score (iHS) in Puerto Rican ancestry individuals at the 9q32 Locus reveals no evidence of selection.
DOI: https://doi.org/10.7554/eLife.25060.021
Figure supplement 2. Global ancestry proportions for the individuals used as reference samples for RelateAdmix in the BioMe H/L.
DOI: https://doi.org/10.7554/eLife.25060.022
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To predict what other populations might be at risk for Steel syndrome, we explored the locus-
specific demographic history in carriers of the COL27A1.pG697R risk haplotype. First, by visual
inspection, we were able to discriminate a single haplotype of 107.5 kb in length that contained 55
SNPs, which uniquely tagged the COL27A1.pG697R variant (R2 = 1). This haplotype was present
only in individuals born in Puerto Rico (N = 25), the Dominican Republic, (N = 2), Columbia (N = 1),
New York City (N = 40) and St. Thomas (N = 1). Genotyping determined that only the haplotype car-
riers from Puerto Rico, New York City and St. Thomas also carried the COL27A1.pG697R variant
(N = 56 in total). Second, we inferred continental ancestry along the genomes of the three Puerto
Rican homozygotes in the discovery cohort. Local ancestry inference is the task of assigning conti-
nental ancestry to genomic segments in an individual with recent ancestors from multiple continents.
For the Puerto Rican homozygotes, we estimated local haplotypic similarity with a reference panel of
African, European and Native American genomes using RFMix (Maples et al., 2013). Examination of
local ancestry on the background of the IBD haplotype in all three homozygous individuals revealed
all to be homozygous for Native American ancestry, suggesting the COL27A1.pG697R arose on a
Native American haplotype (Figure 4B).
To test whether the disease variant arose via genetic drift or selection, we used the IBDNe soft-
ware (Browning and Browning, 2015) to estimate the historical effective population size (Ne) of the
Puerto Rican discovery cohort (N = 2816) (Figure 4C). The IBDNe software calculates the effective
population size of a given population over past generations by modeling the distribution of IBD tract
lengths present in the contemporary population. The analysis suggested evidence of a strong bottle-
neck in Puerto Ricans approximately 9–14 generations ago, with the smallest effective population
sized dating approximately 12 generations ago (estimated Ne = 2580, 95% C.I 2320–2910). This is
consistent with the timing of European immigration and slave trading on the Island, resulting in
admixture and population bottlenecking, followed by demographic growth post-contact (Moreno-
Estrada et al., 2013; Gravel et al., 2013). Finally, to see if there was evidence that the locus had
undergone a recent selective sweep we calculated the integrated haplotype score (iHS)
(Voight et al., 2006; Szpiech and Hernandez, 2014) across chromosome 9 in phased genotype
data for BioMe Puerto Rican samples, but did not observe evidence of selection at the locus (Fig-
ure 4—figure supplement 1). Together, this evidence suggests that the COL27A1.pG697R variant
arose in the ancestral Native American populations that peopled the Caribbean, which underwent a
strong bottleneck during the period of colonization, which may help explain the prevalence of this
disease in amongst contemporary Puerto Rican populations.
Discussion
Here we describe a new approach to utilize genomic data in health systems for identifying and char-
acterizing genetic disorders, the cornerstone of which is the ability to identify related individuals in
the absence of recorded pedigree or genealogy information. By linking medical records of distantly
related patients, identified by shared tracts of genetic homology identical-by-descent (IBD), we dis-
covered a recessive haplotype on 9q32 conferring extreme short stature. Whole genome sequencing
revealed that a mutation (Gly697Arg) in the COL27A1 gene had been previously implicated as the
genetic variant underlying Steel syndrome (Gonzaga-Jauregui et al., 2015; Steel et al., 1993;
Flynn et al., 2010). Population screening indicated that the disease variant is more common than
previously thought in people with Puerto Rican ancestry, and in some other Caribbean populations,
and very rare or absent elsewhere in the world. Extensive analysis of clinical records confirms almost
all features of the recessive disorder in cases, and reveals potential complications that can occur later
in life. An agnostic survey of the medical records of carriers, supplemented by manual chart review,
indicates evidence of joint and spine degradation in heterozygotes. Biochemical modeling suggests
that COL27A1.G697R disrupts a conserved triple helix domain of the alpha-1 collagen in a mecha-
nism similar to dominant forms of other collagen disorders (Persikov et al., 2004). Taken together,
this study indicates that a single mutation in the COL27A1 gene underlies a common collagen disor-
der impacting up to 2% of people of Puerto Rican ancestry.
This is consistent with our finding, supported by previous work (Moreno-Estrada et al., 2013),
demonstrating a founder effect in Puerto Rican populations. Despite segregating at an estimated
carrier rate of 1:51, the COL27A1.pG697R variant was first described very recently (Gonzaga-
Jauregui et al., 2015). This suggests that there may be other highly penetrant disease variants
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segregating at appreciable frequencies in Puerto Rican populations (Anikster et al., 2001;
Cornier et al., 2008; Daniels et al., 2013; Al-Zaidy et al., 2015; Arnold et al., 2013; Lee et al.,
2014), and other understudied founder populations, the discovery of which could lead to new dis-
ease variants and biology. Indeed, although COL27A1 was first implicated as the Steel syndrome
disease locus in an extended family from Puerto Rico recently (Chang et al., 2015), other variants in
COL27A1 have since been linked to Steel syndrome in Indian (Kotabagi et al., 2017) and Emerati
(Gariballa et al., 2017) families revealing additional clinical features of the disease such as hearing
loss. In our own health system, approximately 190,000 patients of Puerto Rican descent are treated
annually (Humes et al., 2011). We estimate that up to 80 may have the severe homozygous form of
the disorder and that the milder heterozygous form could be found in up to 1200 patients. A search
of progress notes, discharge summaries, and operative reports of over 4 million patients in the
Mount Sinai data warehouse discovered mentions of the text term ‘Steel Syndrome’ in 42 patient
records. However, all of these patients were on dialysis for end stage renal disease, indicating that
this mention was a misspelling of vascular Steal Syndrome, which is common in dialysis patients. This
suggests that Steel syndrome might be largely undiagnosed. Attempts are currently being made to
re-contact BioMe participants with suspected Steel syndrome, and a genetic test is now available at
Mount Sinai (website: http://sema4genomics.com/products/test-catalog/).
This study highlights the benefits of incorporating statistical and population genetics approaches
in medical genetic research. First, we demonstrated that leveraging distant relationships via IBD
mapping was better powered for discovery of the COL27A1 variant compared to a more typical
GWAS approach (i.e. genotype, imputation, and SNP association). As sample sizes increase in health
systems and biobanks, the odds of a new individual being a direct or distant relative of someone
already in the database increases exponentially (Henn et al., 2012), enabling the detection of shared
haplotypes harboring rarer causal variants and better-powered IBD mapping studies. Second, we
inferred that COL27A1.pG697R variant arose on a Native American haplotype, and we estimate that
the allele may have segregated at a carrier frequency of 25–30% in pre-Columbian Taı´no populations
and/or been driven to its current frequency by a bottleneck that occurred during the early days of
colonization in Puerto Rico. Therefore this study not only helps estimate population attributable risk
of COL27A1.pG697R in Puerto Rican populations, but also to predict other populations potentially
at risk, including other Caribbean and Taı´no populations. Targeted population screening of
COL27A1.pG697R could potentially provide personalized health management, surveillance for asso-
ciated complications, guidelines for intervention (particularly in newborns [Flynn et al., 2010]), and
improved reproductive choices.
This work also highlights some of the current challenges in the emerging field of genomic medi-
cine. We demonstrated that evidence from EHRs could be readily extracted and retrospectively
used to characterize clinical features of a musculoskeletal genetic disorder. However, features of
many other genetic disorders may not be detectable via routine clinical exam, lab tests and radiolog-
ics, and may not be amenable to such an approach. Furthermore, statistical methods for population-
scale disease variant discovery, which were predominantly developed for cohorts collected for
genetic research, may not be optimally calibrated for discovery in patient populations encountered
in health systems. Finally, many genetic disorders are very rare, or have more complex genetic
underpinnings, which would reduce power for detection using the strategy we have described. How-
ever, recent efforts, such as the Precision Medicine Initiative, that focus on the broad adoption of
genomics in medicine, combined with international efforts to catalog rare genetic diseases, are
primed to increase the rate of incidental genetic diagnosis of disease.
In summary, this work demonstrates the utility of biobanks for exploring full medical phenomes,
and highlights the importance of documenting a wider spectrum of genetic disorders, in large and
diverse populations of humans. In particular, this method provides a bridge between classical medi-
cal genetic methods and those employed in population-level GWAS. Here we note that the
COL27A1 variant is very rare in current large-scale genomic databases used for clinical research.
Thus traditional association strategies and ascertainment bias focused on populations of European
descent would have failed to identify and characterize this disorder and its public health burden. As
ours and other recent studies have demonstrated, EHR-embedded research will be increasingly
important for disentangling the pathology of rare genetic disorders, and understanding the contin-
uum of complex and Mendelian disease. As studies grow in size, and healthcare systems learn to
leverage the wealth of information captured in the EHR, there is a need to provide relevant medical
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information to any patient entering the clinic anywhere in the world. Methods like that described
here allow for precision medicine with a truly global outlook.
Materials and methods
BioMe biobank program
Study participants were recruited from the BioMe Biobank Program of The Charles Bronfman Insti-
tute for Personalized Medicine at Mount Sinai Medical Center from 2007 onward. The BioMe Bio-
bank Program (Institutional Review Board 07–0529) operates under a Mount Sinai Institutional
Review Board-approved research protocol. All study participants provided written informed consent.
Of the approximately 38000 participants currently enrolled in BioMe, N = 10511 unrelated are geno-
typed on the Illumina Infinium OmniExpress (OMNI) array. 5102 of these participants self-report as
‘Hispanic or Latino/a’, 3080 as ‘African American or African’, 2078 as ‘White or Caucasian’, 89 as
‘Mixed’ and 162 as ‘Other’. Country of origin information is available for all but N = 5 participants,
with N = 6553 reporting being born in the United States and the remaining N = 3953 report being
born outside of the US. Parental and grandparental country of origin information is only available for
a small subset of individuals genotyped on the OMNI array (N = 43). An additional N = 10471 partic-
ipants were genotyped on the Illumina Infinium Multi Ethnic Genotyping array (MEGA) v1.0. Of
these, approximately 4704 self-reported ‘Hispanic or Latino/a’ ethnicity, 3143 self-reported as ‘Afri-
can American or African’, 22 self-reported as ‘White/Caucasian’, 708 self-reported as ‘Mixed’ and
1894 self-reported as ‘Other’. Country of birth information was available for all but a small number
of participants (N = 228), with 5190 reporting being born in the United States, and the remaining
5053 self-reporting being born elsewhere. Parental and grandparental country of origin information
is available for 4323 individuals genotyped on the MEGA array.
OmniExpress genotyping and QC
Genotyping of 12749 BioMe participants was performed on the Illumina Infinium OmniExpress plus
HumanExome array. Calling was performed using the GenomeStudio software. A total of 1093 indi-
viduals were removed prior to zCall due to plate failure (N = 672), unambiguous discordance
between genetic and EHR recorded sex (N = 693), a call rate of <98% (N = 834), or deviances in lev-
els of heterozygosity (N = 773 in total). This was defined as having either an inbreeding coefficient
outside the range  0.1 and 0.3 for common alleles (MAF >1%), or between 0.4 and 0.9 for rare
alleles (MAF <1%). Additional quality control of 11656 individuals was performed using PLINK1.7
(Purcell et al., 2007) (RRID:SCR_001757). An individual with a call rate of <99% was also excluded
(N = 1), along with intentional genetic duplicates (PiHat >0.8, N = 444). Site-level quality control
consisted of the removal of SNPs with a call rate of <95% (n = 42217), and the removal of sites that
were significantly out of Hardy-Weinberg equilibrium (p<110 5; n = 39660) when calculated for
self-reported EA, AA and H/L separately. Palindromic sites and those that deviated considerably
from the 1KGP allele frequencies (<40% versus >60%) were also removed to ensure uniform strand-
ing across datasets. After QC steps, 11212 participants and 866864 SNPs remained for downstream
analysis.
IBS relatedness estimates and estimation of inbreeding Co-efficient
Pairwise IBS-based relationship estimates were derived for BioMe participants (N = 11212) using the
RELATEAdmix software (Moltke and Albrechtsen, 2014), which accounts for inflation of IBS statistic
due to admixture linkage disequillibrium in admixed populations. To include allele frequency infor-
mation and global ancestry proportions from ancestral populations relevant for each admixed popu-
lation in the analysis. These were estimated using ADMIXTURE (Alexander et al., 2009) (RRID:SCR_
001263) H/L samples were merged with the Utah Residents (CEPH) with Northern and Western Euro-
pean Ancestry (CEU; N = 100), Yoruba in Ibadan, Nigeria (YRI; N = 100) and Native American (NA;
N = 43; including Nauha, Ayamaran, Mayan and Quechan individuals) and used as input for the
ADMIXTURE software, which was run unsupervised at k = 3. ADMIXTURE analysis confirmed that
NA reference panel comprised >99% proportion Native American genetic ancestry (Figure 4—fig-
ure supplement 2). European-American (EA) individuals were merged with the CEU and a panel of
self-reported Ashkenazi Jewish individuals genotyped on OMNI from BioMe (AJ; N = 100) and run
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unsupervised at k = 2. AA samples were merged with the CEU and YRI reference panels and run
unsupervised at k = 2. After intersecting with reference panels 99296 SNPs were used as the input
for RELATEAdmix.
Principal component analysis
Principal Component Analysis (PCA) was performed using the SMARTPCAv10210 software from the
EIGENSOFTv5.0.1 (RRID:SCR_004965) (Price et al., 2006) in 10511 unrelated BioMe participants.
Regions containing the Human Leukocyte Antigen (chr6: 27000000–35000000 (NCBI37/hg19)), Lac-
tase gene (chr2:135000000–137000000 (NCBI37/hg19)) and a common inversion (chr8:6000000–
16000000 (NCBI37/hg19)), all of which are regions known to confound PCA analysis were removed
from the genotype data prior to analysis. Data were merged with a reference panel of 2504 individu-
als from Phase 3 of the 1KGP (RRID:SCR_006828) (The 1000 Genomes Project Consortium, 2015)
that was constructed by extracting OmniExpress sites from whole-genome sequence data. Following
this, a further two other relevant reference panels were added: the NA (N = 43), and AJ (N = 100)
panels described above. A total of 174468 SNPs remained after intersecting the data with these ref-
erence panels.
Identity-by-descent tract inference and clustering
Phased genotype data were filtered to MAF >0.01 and converted to PLINK format using the
FCGENE software (Roshyara and Scholz, 2014) (we avoided using PLINK software for the conver-
sion process in order to retain the phase information). Recombination maps from HapMap II (Build
GRCh37/hg19) were intersected with the genotyped sites (n = 490510 SNPs). GERMLINE (RRID:
SCR_001720) (Gusev et al., 2009) was used to infer tracts of identity by descent >3 cM across all
pairs of BioMe individuals (N = 11212) using the following flags: ‘-min_m 3 -err_hom 0 -err_het 2 -
bits 25 –haploid’. IBD haplotypes that fell within or overlapped with centromeres, telomeres and
regions of low complexity were removed from the GERMLINE output using an in-house Ruby script.
Additional quality control measures consisted of the exclusion of regions of the genome where the
depth of IBD-sharing (that is, the number of pairwise IBD-haplotypes that contain a given locus of
the genome) exceeded 4 standard deviations from the genome-wide mean (Figure 2—figure sup-
plement 6).
IBD clustering to identify ‘cliques’ of three or more IBD haplotypes shared between multiple indi-
viduals was then performed using the efficient connect-component-based clustering version of the
Dash Associated Shared Haplotypes algorithm (DASH) (Gusev et al., 2011), using the default
parameters. As a further quality control measure IBD-sharing ‘cliques’ inferred by DASH that exhib-
ited excessive sharing (which we defined as clique membership that exceeded 4 s.d. above the
genome-wide mean) were removed (Figure 2—figure supplement 7). Data was outputted from
DASH in PLINK tped format, and alleles were encoded as; homozygote member in a clique as ‘2’,
heterozygote member as ‘1’ and everyone else not a member in the clique encoded as ‘0’.
Population-level IBD sharing
We calculated the length of any pairwise IBD tract (or sum of the lengths if a pair of individuals
shared more than one tract IBD) for each IBD sharing pair within each population to obtain an esti-
mate of the mean and variance of pairwise sharing per population. To compare the tract length dis-
tribution between populations (of size N), we first binned pairwise IBD tracts by length bin in 0.01
cM increments. We then summed the number of pairwise IBD tracts falling into each length bin (x),
and divided this number by the number of possible pairwise IBD sharing for each population: N*(N-
1)/2.
Height measurement and transformation
A self-reported measurement of height in feet and inches was recorded for each participant at
enrollment into the BioMe program. Raw height data were stratified on the basis of sex for all indi-
viduals who were inferred to be of Puerto Rican ancestry (N = 2816). Height data was then log trans-
formed and converted to age-adjusted Z-scores. Participants were excluded on the basis of age
reported at the point of enrollment, with a minimum cut-off of 18 years old for females (N = 0) and
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22 for males (N = 0), and a maximum cut off of 79 years old for both sexes (N = 194) leaving a total
of n = 2622 PR.
Association of IBD-cliques with height under a recessive model
Association of IBD clique membership with height as a continuous trait was performed under a
recessive model using PLINKv1.9 (Chang et al., 2015) using the ‘–linear recessive’ flag. Age and sex
adjusted Z-scores for height were used as the outcome variable. IBD clique membership was used as
the primary predictor variable and the first five PCA eigenvectors were used as covariates. The
model was run across a total of 2622 PR ancestry individuals and a total of 480 IBD-cliques where at
least 3 individuals were homozygous for the IBD haplotype.
Genome wide association of imputed data under a recessive model
Genotype data for all of the BioMe individuals ascertained on the Illumina OMNI Express array
(N = 11212) were phased together using SHAPEIT2 (Delaneau et al., 2011; O’Connell et al., 2014).
Imputation was subsequently performed in 5 MB chunks using IMPUTE2 (RRID:SCR_013055)
(Howie et al., 2009)via the flags ‘-Ne 20000 -buffer 250 -filt_rules_l ’ALL<0.0002’ ’ALL>0.9998’’ with
a reference panel derived from phase 3 data from the 1KGP. A total of 46538253 SNPs were
imputed from 828109 directly genotyped SNPs.
We ran a recessive GWAS on the same 2622 inferred Puerto Rican ancestry individuals used in
our recessive IBD-mapping model. The association was run over hard-called data using the
PLINKv1.9 software using the ‘–linear recessive’ flag. Age and sex adjusted Z-scores for height were
used as the phenotypic outcome and the first five PC eigenvectors were used as covariates. Analysis
was restricted to SNPs with >= 2 observations of individuals homozygous for the minor allele (as the
only 2 of the 3 homozygotes had been imputed correctly), and SNPs with an INFO score of >= 0.3
(n = 10007795 SNPs in total).
Whole genome sequencing
Genomic libraries were prepared from DNA obtained for the four IBD homozygous individuals. DNA
was sheared to 300 bp on a Covaris E220, libraries were made using the NEBNext Ultra DNA Library
Prep kit for Illumina. The libraries were submitted for Whole Genome Sequencing (WGS) at the
Mount Sinai Genomic Core using the Illumina HiSeq 2500 system, performed by the Genomics Core
Facility of the Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at
Mount Sinai. Reads were aligned to the NCBI37/hg19 reference genome and variants were called
using the sequence analysis pipeline by Linderman et al. (2014) Variant calls and coverage at every
site at the genomic interval spanned by the candidate IBD haplotype (chr9:112000000–118000000
bp (NCBI37/hg19)) were obtained using the ‘-out_mode EMIT_ALL_SITES’ flag in GATKv3.2–72
(RRID:SCR_001876). For summary statistics of whole genome sequencing (WGS) see
Supplement file 1.
In silico analysis and validation of COL27A1.pG967R
WGS variant calls were annotated with allele frequency information and in silico prediction scores for
SIFT, PhyloP, GERP generated using snpEffv3.0 (RRID:SCR_005191) as part of the sequence analysis
pipeline published by Linderman et al. (2014). We identified all genomic variants that were present
in at least 6 copies across the four IBD-homozygotes and that lay within the shared boundary of the
IBD haplotype. Using this criteria, only one rare, coding variant was found to be shared between all
four homozygotes, namely a point mutation in the gene COL27A1 (g.9:116958257 .C>G,
NM_032888.1, p.G697R, rs140950220) which was present in 7 copies (with 3 individuals being
homozygous, and the fourth being heterozygous). The rs140950220 G/C allele status was validated
by Sanger sequencing of exon 7 in the COL27A1 gene in all four individuals. We also validated
COL27A1.pG697R status in individuals carrying the significant IBD-clique at 9q32 using the Fluidigm
SNPType assay adhering to the standard protocol. All individuals carrying at least one copy of the
top IBD-haplotype (N = 59) were genotyped for the rs140950220 variant in addition to a panel of
age and sex matched Puerto Rican ancestry controls (N = 59).
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Genotyping COL27A1.pG697R in a Multi-Ethnic population of PAGE
We estimated the frequency of the COL27A1.pG697R (dbSNP = rs140950220) variant in the Popula-
tion Architecture using Genomics and Epidemiology (PAGE) study. The PAGE study comprises a
diverse global reference panel from five studies. African-American and Hispanic/Latina women from
the Women’s Health Initiative (WHI), a multi-center cohort study investigating post-menopausal
women’s health in the US and recruited women at 40 centers across the US. Self-identified Hispanic/
Latino/as from four sites in San Diego, CA, Chicago, IL, Bronx, NY, and Miami, FL as part of the His-
panic Community Health Study/Study of Latinos (HCHS/SOL). African American, Japanese American,
and Native Hawaiian participants from the Multiethnic Cohort (MEC) prospective cohort study
recruiting men and women from Hawaii and California. The Global Reference Panel (GRP) created
by Stanford University contributed samples including; a population sample of Andean individuals pri-
marily of Quechuan/Aymaran ancestry from Puno, Peru; a population sample of Easter Island (Rapa
Nui), Chile; individuals of indigenous origin from Oaxaca, Mexico, Honduras, Colombia, the Nama
and Khomani KhoeSan populations of the Northern Cape, South Africa; the Human Genome Diver-
sity Panel in collaboration with the Centre Etude Polymorphism Humain (CEPH) in Paris; and the
Maasai in Kinyawa, Kenya (MKK) dataset from the International Hapmap Project hosted at Coriell.
Finally, the BioMe biobank in the Mount Sinai health system, New York City, contributed African-
American, Hispanic/Latino/a, and participants who reported as mixed or other ancestry to the PAGE
study,~50% of whom were born outside New York City and for whom country-of-birth information
was available. In all, participants in the PAGE Study represent a global reference panel of 112 popu-
lations ranging from 4 to 17773 individuals in size (Supplement file 4). Samples in the PAGE study
were genotyped on the Illumina Multi-Ethnic Genotyping Array (MEGA), which included direct geno-
typing of the rs140950220 variant. A total of 53338 PAGE and GRP samples were genotyped on the
MEGA array at the Johns Hopkins Center for Inherited Disease Research (CIDR), with 52878 samples
successfully passing CIDR’s QC process. Genotyping data that passed initial quality control at CIDR
were released to the Quality Assurance/Quality Control (QA/QC) analysis team at the University of
Washington Genetics Coordinating Center (UWGCC). The UWGCC further cleaned the data accord-
ing to previously described methods (Laurie et al., 2010) and returned genotypes for 51520 sub-
jects. A total of 1705969 SNPs were genotyped on the MEGA. The COL27A1.pG697R variant
passed the following filters; (1) CIDR technical filters, (2) SNPs with missing call rate >= 2%, (3) SNPs
with more than 6 discordant calls in 988 study duplicates, (4) SNPs with greater than 1 Mendelian
errors in 282 trios and 1439 duos, (5) SNPs with a Hardy-Weinberg p<10 10, (6) positional
duplicates.
Structural modeling of the COL27A1.PG697R missense variant
We downloaded X-ray crystal coordinates (1CAG from Bella et al., 1994.; www.pdb.org) on January
21, 2017. Visualization and modeling of the missense variant were performed in PyMol (www.pymol.
org; RRID:SCR_000305).
Phenome-Wide association study
To test for clinical symptoms of Steel syndrome in COL27A1.pG967R carriers, we performed a Phe-
nome-Wide Association Study (PheWas) with EHR-derived ICD9 billing codes as the phenotypic out-
come. In the association model, for each individual ICD9 codes were encoded as ‘1’ if the ICD9 was
present in their EHR, and ‘0’ if the ICD9 code was absent. Carrier status for COL27A1.pG697R was
used as the primary predictor variable, with heterozygous individuals encoded as ‘1’, non-carriers
encoded a ‘0’ and homozygotes excluded from the analysis. We restricted the analysis to carriers of
COL27A1.pG697R (n = 106) and non-carriers (n = 4480) who either reported being born in Puerto
Rico or who were US-born, self-identified as H/L and overlapped with Puerto Rican born individuals
in principal component analysis. Age, sex and the first 5 principal components were included as
covariates in our model. The regression was performed using four methods; Generalized Linear
Models (GLM) using the glm() function in Rv3.2.1; a score test based on the saddlepoint approxima-
tion (SPATest) using the SPAtest() function in Rv3.2.1; a score test using a base adjustment for rare
variants (Firth test) using the logistf() function in Rv3.2.1; and a linear mixed model using the
GCTAv1.24.2 software with a genetic relationship matrix constructed from 281666 SNPs shared
between the OMNI and MEGA arrays (MAF >= 1%). To adjust for multiple tests, raw p-values were
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adjusted for false discovery rate using the p.adjust() function in R, and only those below an FDR
adjusted p-value of 0.05 were reported as significant.
Clinical review of patient records
Information from inpatient, outpatient, emergency and private practice settings housed in the Mount
Sinai health system since 2004 was reviewed by two clinical experts independently. This data
includes laboratory reports, radiological data, pathology results, operative and inpatient/outpatient
progress notes, discharge summaries, pharmacy, and nurses reports. The clinical experts examined
for clinical features similar to those reported for Steel syndrome cases in Flynn et al. (2010), includ-
ing developmental dysplasia of the hip (or congenital hip dysplasia), carpal coalition, scoliosis, and
joint and spine anomalies. Both clinical experts reviews patient records independently and compared
notes to resolve discrepancies. They reviewed the records of the 34 youngest COL27A1.pG697R car-
riers (mean age 42), and compared their findings to 31 randomly selected age and sex matched
Puerto Rican non-carriers, and also to published reports of population prevalences of key clinical fea-
tures for similar age groups where available.
Local ancestry estimation
Due to the process of recombination, individuals from populations that have undergone recent
admixture can exhibit a mosaic of genetic ancestry along their genome. Their genetic ancestry at a
given genomic segment (referred to as local ancestry), can be inferred from genotype data with the
use of non-admixed reference panels of known continental ancestry. We calculated local ancestry in
the three homozygous Puerto Rican individuals genotyped on OMNI by first extracting the intersect-
ing sites of the Affymetrix 6.0 array (n = 593729 SNPs in total) and merging them with 3 ancestral
reference panels. These reference panels consisted of the CEU and YRI samples from the 1KGP in
addition to the Native American reference panel described previously that were used as a proxy for
European, African and Native American ancestral source populations, respectively. RFMix
(Maples et al., 2013) was used to infer local ancestry.
Calculation of historical effective population size in Puerto Ricans
To investigate evidence of a founder effect in Puerto Ricans we ran the IBDNe software
(Browning and Browning, 2015) in 2816 Puerto Ricans from the discovery effort using the cleaned
set of pairwise IBD-haplotypes inferred using GERMLINE. IBDNe was run using the default parame-
ters, including an assumed generation time of 25 years.
Data availability
All scripts used to generate main and supplementary figures for this manuscript are available for
download on GitHub (https://github.com/gillian-belbin/ibdmapping_ehr_figscripts [Belbin, 2017]; a
copy is archived at https://github.com/elifesciences-publications/ibdmapping_ehr_figscripts). The
data frames of analysis results that were used to generate the main and supplementary figures are
located here: http://research.mssm.edu/kennylab/data_source_file.tar.gz
Web resources
BioMe OmniExpress data: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=
phs000888.v1.p1
BioMe MEGA data: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=
phs000925
PAGE MEGA data: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=
phs000356
Location of Native American panels: ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/working/
20130711_native_american_admix_train/
Software used in the analysis:
SMARTPCA: https://github.com/DReichLab/EIG
ADMIXTURE: https://www.genetics.ucla.edu/software/admixture/download.html
RelateAdmix: http://www.popgen.dk/software/index.php/RelateAdmix#Download
RFMix: https://sites.google.com/site/rfmixlocalancestryinference/
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GERMLINE: http://www.cs.columbia.edu/~gusev/germline/
DASH: http://www1.cs.columbia.edu/~gusev/dash/
PyMol: www.pymol.org
IBDNe: http://faculty.washington.edu/browning/ibdne.html
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